Summer Haven Investment Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Summer Haven Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$17.74 - $31.87 $76,760 - $137,901	-4,327 Reduced 23.8%	13,851 $269,000
Q1 2023 Apr 13, 2023	BUY	$25.06 - $34.09 $14,284 - $19,431	570 Added 3.24%	18,178 $515,000
Q4 2022 Jan 18, 2023	BUY	$24.98 - $39.77 $7,494 - $11,931	300 Added 1.73%	17,608 $0
Q3 2022 Oct 20, 2022	SELL	$26.42 - $47.12 $34,240 - $61,067	-1,296 Reduced 6.97%	17,308 $457,000
Q1 2022 May 04, 2022	BUY	$44.58 - $52.6 $38,427 - $45,341	862 Added 4.86%	18,604 $921,000
Q3 2021 Oct 20, 2021	BUY	$43.79 - $55.78 $776,922 - $989,648	17,742 New	17,742 $990,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summer Haven Investment Management, LLC with notifications on news.